CD4 and neoplasm: Specifically, Fap2 binds to a T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT) and impairs the function of CD4+ T, CD8+ T, and NK cells; moreover, it reduces cytotoxicity, resulting in tumor escape from immunosurveillance (18).